Search
Displaying results 851 to 860 of 1201.
State Secretary Judith Pirscher visits the HZI
The MICROSTAR project, with a volume of around 30 million euros, aims to find solutions to the increasing global challenges posed by infectious diseases. Over billions of years of evolution, all organisms have developed a variety of mechanisms to resist difficult…
Groundbreaking for the Centre for Individualised Infection Medicine (CiiM)
"The COVID-19 pandemic has just shown us how important infection research and personalised medicine are - and that research findings need to to be transferred more quickly from bench to bedside," said Lower Saxony's Science Minister Falko Mohrs. "The life sciences are…
Exploring humans, animals and the environment as one
In accordance with a decision made in November 2019, the Helmholtz Centre for Infection Research is establishing a new location in Greifswald: the Helmholtz Institute for One Health (HIOH). One Health research investigates the interface between human health, animal…
Next generation scientists deepen their knowledge of translational medicine and drug production
The ENLIGHT-TEN+ network (European Network Linking Informatics and Genomics of Helper T cells in Tissues) educates 15 young scientists in the field of immunology at academic and non-academic institutions in ten European countries. Prof. Jochen Hühn, head of the…
World Day for Laboratory Animals 2024
The aim of research at the HZI is to develop new and faster diagnostic procedures, new active substances, for example against resistant germs, and new therapies against infectious diseases. The HZI is consistently committed to the so-called 3R principle with the aim of…
Christopher Baum: “We have to collaborate more closely on the programmes for young scientists“
The economic concerns of the MHH have attracted a great deal of attention over the last few years. This phase was very much defined by figures and the economic recovery of the MHH, while the scientific changes went on in the background. What kind of phoenix is rising…
Searching for the microbial treasure
It is long known that bacterial pathogens are increasingly developing resistance to pharmaceutical agents. Nevertheless, since the 1980s, no new active ingredient has been discovered that can combat resistance in gram-negative pathogens in the long term. In addition to…
New antibiotic against river blindness and lymphatic filariasis pathogens
Infections with worms from the filarial group, also known as filariasis, can lead to river blindness and, if left untreated, to elephantiasis - a disease in which extremities become greatly enlarged due to destruction of the lymphatic vessels. The lives of those…